DNLI Denali Therapeutics Inc.

NASDAQ
$18.40

Denali Therapeutics Inc. (DNLI) Earnings News

Earnings press releases, previews and reviews for Denali Therapeutics Inc. (DNLI), newest first. Our most recent is review: Denali's AVLAYAH Launch Blows Past Guidance as Q4 Outlook Nearly Triples, but a Shrinking Stock Prices In Doubt.